Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Review Question - QID 204423

In scope icon L 1 A
QID 204423 (Type "204423" in App Search)
A 32-year-old woman with Graves' disease is undergoing treatment with radioactive iodine. Her initial presentation consisted of symptoms of sweating, weight-loss, and intermittent palpitations along with a physical examination significant for mild-to-moderate exophthalmos. After completing one week of radioactive iodine therapy, she reports worsening of her proptosis, with increased pain and worsened periorbital edema. Which of the following could have prevented the worsening of this patient's exophthalmos?

Giving a larger dose of radioiodine therapy

0%

0/0

Initiation of beta-blocker at time of radioiodine therapy

0%

0/0

Begin methimazole concurrent with initiating radioiodine therapy

0%

0/0

Pre-treatment with prednisone prior to initiating radioiodine therapy

0%

0/0

This is an expected outcome from radioactive iodine therapy, no preventive options are available

0%

0/0

Select Answer to see Preferred Response

bookmode logo Review TC In New Tab

This patient's Graves' ophthalmopathy was worsened by the initiation of radioactive iodine. Pretreatment with glucocorticoids, such as prednisone, may prevent this adverse effect.

Worsening of exophthalmos is due to the release of excess thyroid hormone during the destruction of thyroid cells by the radioactive iodine. Administration of radioactive iodine may also precipitate a thyroid storm through an identical mechanism. Preventive administration of steroids for several months (2-3) followed by a brief taper prior to initiating radioiodine therapy is recommended for patients with mild, moderate, or progressive ophthalmopathy. Patients without obvious ophthalmopathy initially are at a much lower risk of exacerbation with the start of radioactive iodine treatment.

Reid and Wheeler discuss the diagnosis and management of hyperthyroidism. In the US, radioiodine therapy is the first-choice treatment for hyperthyroidism and Graves' disease. Graves opthalmopathy may develop or worsen in 15% of patients who receive radioiodine therapy. Post-treatment hypothyroidism may be associated with worsening of ophthalmopathy; therefore, lower doses of radioiodine therapy may be considered.

Chen et al. investigate changes in Graves' ophthalmopathy after undergoing radioiodine or anti-thyroid treatment. They find that thyroid function is likely the most important factor in the worsening of Graves' ophthalmopathy regardless of treatment modality. Thus, they recommend striving for euthyroidism as a goal of treatment.

Illustration A shows a management algorithm for Graves' ophthalmopathy. Illustration B demonstrates the pathogenesis of Graves' ophthalmopathy; Graves' ophthalmopathy is due to an inflammatory autoimmune response that leads to deposition of glycosaminoglycans in the extraocular muscles and retroorbital connective tissues. There are numerous hypotheses as to the specific autoantibodies and targets responsible.

Incorrect Answers:
Answer 1: A larger dose of radioiodine could have led to an even greater exacerbation of the patient's exophthalmos. A smaller dose could have mitigated the effect of the radioiodine.
Answer 2: Beta-blockers act to control the symptoms of hyperthyroidism, notably tachycardia and palpitations; initiating a beta-blocker would not be expected to decrease the risk or severity of the worsening of this patient's ophthalmopathy.
Answer 3: Antithyroid drugs should be stopped prior to initiating therapy with radioactive iodine.
Answer 5: Pretreatment with glucocorticoids has been shown to decrease the risk or extent of worsening exophthalmos after initiating radioactive iodine therapy.

ILLUSTRATIONS:
REFERENCES (2)
Authors
Rating
Please Rate Question Quality

0.0

  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon

(0)

Attach Treatment Poll
Treatment poll is required to gain more useful feedback from members.
Please enter Question Text
Please enter at least 2 unique options
Please enter at least 2 unique options
Please enter at least 2 unique options